Transforming growth factor β1 enhances tumor promotion in mouse skin carcinogenesis

Rolando Pérez-Lorenzo, Lauren Mordasky Markell, Kelly A. Hogan, Stuart H. Yuspa, Adam Bleier Glick

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Transforming growth factor b1 (TGFβ1) expression is elevated by tumor promoters in the mouse skin, but its role in tumor pro-motion has not been well defined. To investigate this, we have compared TGFβ1+/+ and +/- mice in a two-stage skin chemical carcinogenesis protocol. Surprisingly, TGFβ1+/- mice had fewer number and incidence of benign papillomas, reduced epi-dermal and tumor cell proliferation and reduced epidermal TGFβ1 and nuclear p-Smad2 localization in response to the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) compared with TGFβ1+/+ mice. Maximal TPA activation of protein kinase C (PKCα) as measured by activity assays and activation of target genes and induction of cornified envelopes correlated with TGFb1 gene dosage in keratinocytes and addition of exogenous TGFb1 restored the cornification defect in TGFβ1+/- keratinocytes. Similarly, inhibition of ALK5-suppressed TPA-mediated PKCa activation suggesting that physiological levels of TGFb1 are required for maximal activation of PKC-dependent mitogenic responses. Paradoxically, the TPA-induced inflammatory response was greater in TGFbβ1/+ skin, but TGFβ1+/+ papillomas had more tumor infiltrating myeloperoxidase-positive cells and pro-inflammatory gene expression was elevated in v-rasHa-transduced TGFβ1+/+ but not TGFβ1+/- keratinocytes. Thus, ras activation switches TGFβ1 to a pro-inflammatory cytokine. Despite this differential proliferative and inflammatory response to TPA and enhanced papilloma formation in the TGFβ1+/+ mice, the frequency of malignant conversion was reduced compared with TGFβ1+/- mice. Therefore, TGFb1 promotes benign tumors by modifying tumor promoter-induced cell proliferation and inflammation but retains a suppressive function for malignant conversion.

Original languageEnglish (US)
Pages (from-to)1116-1123
Number of pages8
JournalCarcinogenesis
Volume31
Issue number6
DOIs
StatePublished - Feb 19 2010

Fingerprint

Transforming Growth Factors
Carcinogenesis
Skin
Tetradecanoylphorbol Acetate
Neoplasms
Papilloma
Keratinocytes
Carcinogens
Protein Kinase C
Cell Proliferation
Gene Dosage
Epidermal Growth Factor
Transcriptional Activation
Peroxidase
Cytokines
Inflammation
Gene Expression

All Science Journal Classification (ASJC) codes

  • Cancer Research

Cite this

Pérez-Lorenzo, Rolando ; Markell, Lauren Mordasky ; Hogan, Kelly A. ; Yuspa, Stuart H. ; Glick, Adam Bleier. / Transforming growth factor β1 enhances tumor promotion in mouse skin carcinogenesis. In: Carcinogenesis. 2010 ; Vol. 31, No. 6. pp. 1116-1123.
@article{a5964ed5f8294b07902149ea9e01d9fa,
title = "Transforming growth factor β1 enhances tumor promotion in mouse skin carcinogenesis",
abstract = "Transforming growth factor b1 (TGFβ1) expression is elevated by tumor promoters in the mouse skin, but its role in tumor pro-motion has not been well defined. To investigate this, we have compared TGFβ1+/+ and +/- mice in a two-stage skin chemical carcinogenesis protocol. Surprisingly, TGFβ1+/- mice had fewer number and incidence of benign papillomas, reduced epi-dermal and tumor cell proliferation and reduced epidermal TGFβ1 and nuclear p-Smad2 localization in response to the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) compared with TGFβ1+/+ mice. Maximal TPA activation of protein kinase C (PKCα) as measured by activity assays and activation of target genes and induction of cornified envelopes correlated with TGFb1 gene dosage in keratinocytes and addition of exogenous TGFb1 restored the cornification defect in TGFβ1+/- keratinocytes. Similarly, inhibition of ALK5-suppressed TPA-mediated PKCa activation suggesting that physiological levels of TGFb1 are required for maximal activation of PKC-dependent mitogenic responses. Paradoxically, the TPA-induced inflammatory response was greater in TGFbβ1/+ skin, but TGFβ1+/+ papillomas had more tumor infiltrating myeloperoxidase-positive cells and pro-inflammatory gene expression was elevated in v-rasHa-transduced TGFβ1+/+ but not TGFβ1+/- keratinocytes. Thus, ras activation switches TGFβ1 to a pro-inflammatory cytokine. Despite this differential proliferative and inflammatory response to TPA and enhanced papilloma formation in the TGFβ1+/+ mice, the frequency of malignant conversion was reduced compared with TGFβ1+/- mice. Therefore, TGFb1 promotes benign tumors by modifying tumor promoter-induced cell proliferation and inflammation but retains a suppressive function for malignant conversion.",
author = "Rolando P{\'e}rez-Lorenzo and Markell, {Lauren Mordasky} and Hogan, {Kelly A.} and Yuspa, {Stuart H.} and Glick, {Adam Bleier}",
year = "2010",
month = "2",
day = "19",
doi = "10.1093/carcin/bgq041",
language = "English (US)",
volume = "31",
pages = "1116--1123",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "6",

}

Transforming growth factor β1 enhances tumor promotion in mouse skin carcinogenesis. / Pérez-Lorenzo, Rolando; Markell, Lauren Mordasky; Hogan, Kelly A.; Yuspa, Stuart H.; Glick, Adam Bleier.

In: Carcinogenesis, Vol. 31, No. 6, 19.02.2010, p. 1116-1123.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Transforming growth factor β1 enhances tumor promotion in mouse skin carcinogenesis

AU - Pérez-Lorenzo, Rolando

AU - Markell, Lauren Mordasky

AU - Hogan, Kelly A.

AU - Yuspa, Stuart H.

AU - Glick, Adam Bleier

PY - 2010/2/19

Y1 - 2010/2/19

N2 - Transforming growth factor b1 (TGFβ1) expression is elevated by tumor promoters in the mouse skin, but its role in tumor pro-motion has not been well defined. To investigate this, we have compared TGFβ1+/+ and +/- mice in a two-stage skin chemical carcinogenesis protocol. Surprisingly, TGFβ1+/- mice had fewer number and incidence of benign papillomas, reduced epi-dermal and tumor cell proliferation and reduced epidermal TGFβ1 and nuclear p-Smad2 localization in response to the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) compared with TGFβ1+/+ mice. Maximal TPA activation of protein kinase C (PKCα) as measured by activity assays and activation of target genes and induction of cornified envelopes correlated with TGFb1 gene dosage in keratinocytes and addition of exogenous TGFb1 restored the cornification defect in TGFβ1+/- keratinocytes. Similarly, inhibition of ALK5-suppressed TPA-mediated PKCa activation suggesting that physiological levels of TGFb1 are required for maximal activation of PKC-dependent mitogenic responses. Paradoxically, the TPA-induced inflammatory response was greater in TGFbβ1/+ skin, but TGFβ1+/+ papillomas had more tumor infiltrating myeloperoxidase-positive cells and pro-inflammatory gene expression was elevated in v-rasHa-transduced TGFβ1+/+ but not TGFβ1+/- keratinocytes. Thus, ras activation switches TGFβ1 to a pro-inflammatory cytokine. Despite this differential proliferative and inflammatory response to TPA and enhanced papilloma formation in the TGFβ1+/+ mice, the frequency of malignant conversion was reduced compared with TGFβ1+/- mice. Therefore, TGFb1 promotes benign tumors by modifying tumor promoter-induced cell proliferation and inflammation but retains a suppressive function for malignant conversion.

AB - Transforming growth factor b1 (TGFβ1) expression is elevated by tumor promoters in the mouse skin, but its role in tumor pro-motion has not been well defined. To investigate this, we have compared TGFβ1+/+ and +/- mice in a two-stage skin chemical carcinogenesis protocol. Surprisingly, TGFβ1+/- mice had fewer number and incidence of benign papillomas, reduced epi-dermal and tumor cell proliferation and reduced epidermal TGFβ1 and nuclear p-Smad2 localization in response to the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) compared with TGFβ1+/+ mice. Maximal TPA activation of protein kinase C (PKCα) as measured by activity assays and activation of target genes and induction of cornified envelopes correlated with TGFb1 gene dosage in keratinocytes and addition of exogenous TGFb1 restored the cornification defect in TGFβ1+/- keratinocytes. Similarly, inhibition of ALK5-suppressed TPA-mediated PKCa activation suggesting that physiological levels of TGFb1 are required for maximal activation of PKC-dependent mitogenic responses. Paradoxically, the TPA-induced inflammatory response was greater in TGFbβ1/+ skin, but TGFβ1+/+ papillomas had more tumor infiltrating myeloperoxidase-positive cells and pro-inflammatory gene expression was elevated in v-rasHa-transduced TGFβ1+/+ but not TGFβ1+/- keratinocytes. Thus, ras activation switches TGFβ1 to a pro-inflammatory cytokine. Despite this differential proliferative and inflammatory response to TPA and enhanced papilloma formation in the TGFβ1+/+ mice, the frequency of malignant conversion was reduced compared with TGFβ1+/- mice. Therefore, TGFb1 promotes benign tumors by modifying tumor promoter-induced cell proliferation and inflammation but retains a suppressive function for malignant conversion.

UR - http://www.scopus.com/inward/record.url?scp=77953931492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953931492&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgq041

DO - 10.1093/carcin/bgq041

M3 - Article

C2 - 20172950

AN - SCOPUS:77953931492

VL - 31

SP - 1116

EP - 1123

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 6

ER -